NCT03607071View on ClinicalTrials.gov

Outcome of Steroid Therapy for Myocardial Inflammation in Scleroderma

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Myocardial Inflammation
Interventions
DRUG

Prednisolone and taper

Prednisolone 30 mg/d and taper 5-10 mg per 2 weeks until off at week 24.

Trial Locations (1)

40002

Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen

All Listed Sponsors
lead

Khon Kaen University

OTHER

NCT03607071 - Outcome of Steroid Therapy for Myocardial Inflammation in Scleroderma | Biotech Hunter | Biotech Hunter